Evidence map›Paper›PMID 28660426›Full record

ArticleCell biochemistry and biophysics2017

Recent Developments in the Probes and Assays for Measurement of the Activity of NADPH Oxidases.

Jacek Zielonka, Micael Hardy, Radosław Michalski, Adam Sikora, Monika Zielonka, Gang Cheng, Olivier Ouari, Radosław Podsiadły, Balaraman Kalyanaraman

Open access · greenAbstract read
In one paragraph

Article in Cell biochemistry and biophysics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. The Effectiveness of Vitamin E Treatment in Alzheimer's Disease.International journal of molecular sciences · 2019
    Review
  10. Article
  11. Article
  12. High-Throughput Screening of NOX Inhibitors.Methods in molecular biology (Clifton, N.J.) · 2019
    Article
  13. Vitamin E and Alzheimer's disease: what do we know so far?Clinical interventions in aging · 2019
    Review
  14. Review
  15. Review
  16. Review
  17. Polypharmacological Profiles Underlying the Antitumor Property ofOxidative medicine and cellular longevity · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 3 countries.

Jacek ZielonkaDepartment of Biophysics and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA. jzielonk@mcw.edu.ORCID http://orcid.org/0000-0002-2524-0145
Micael HardyAix Marseille Univ, CNRS, ICR, 13013, Marseille, France.
Radosław MichalskiInstitute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924, Lodz, Poland.
Adam SikoraInstitute of Applied Radiation Chemistry, Faculty of Chemistry, Lodz University of Technology, Zeromskiego 116, 90-924, Lodz, Poland.
Monika ZielonkaDepartment of Biophysics and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Gang ChengDepartment of Biophysics and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Olivier OuariAix Marseille Univ, CNRS, ICR, 13013, Marseille, France.
Radosław PodsiadłyInstitute of Polymer and Dye Technology, Faculty of Chemistry, Lodz University of Technology, Stefanowskiego 12/16, 90-924, Lodz, Poland.
Balaraman KalyanaramanDepartment of Biophysics and Free Radical Research Center, Medical College of Wisconsin, 8701 Watertown Plank Road, Milwaukee, WI, 53226, USA.
Medical College of Wisconsin · USLodz University of Technology · PLCentre National de la Recherche Scientifique · FR

Funding

CYP2E1 Mediated Mitochondrial Injury and Cell Damage in Alcohol Liver DiseaseR01AA022986 · NIAAA · UNIVERSITY OF PENNSYLVANIA · PI AVADHANI, NARAYAN G, KALYANARAMAN, BALARAMAN · 2015 to 2019
$2.6M
Agence Nationale de la Recherche ANR-16-CE07-0023-01National Institute on Alcohol Abuse and Alcoholism R01 AA022986NIAAA NIH HHS R01 AA022986Polish National Science Centre 2015/18/E/ST4/00235
6 · The paper itself

Abstract

NADPH oxidases are a family of enzymes capable of transferring electrons from NADPH to molecular oxygen. A major function of NADPH oxidases is the activation of molecular oxygen into reactive oxygen species. Increased activity of NADPH oxidases has been implicated in various pathologies, including cardiovascular disease, neurological dysfunction, and cancer. Thus, NADPH oxidases have been identified as a viable target for the development of novel therapeutics exhibiting inhibitory effects on NADPH oxidases. Here, we describe the development of new assays for measuring the activity of NADPH oxidases enabling the high-throughput screening for NADPH oxidase inhibitors.

Indexed as

Cardiovascular DiseasesChromatography, High Pressure LiquidElectron Spin Resonance SpectroscopyFluorescent DyesHigh-Throughput Screening AssaysHumansHydrogen PeroxideLuminescent MeasurementsNADPH OxidasesNeoplasmsOxidation-ReductionSpectrophotometrySuperoxidesFluorescent DyesHydrogen PeroxideNADPH OxidasesSuperoxidesFluorescent probesHigh-throughput screeningHPLCNADPH oxidaseReactive oxygen species

Identifiers

PMID28660426
PMCPMC5693611
OpenAlexW2731183656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.